-+ 0.00%
-+ 0.00%
-+ 0.00%

Arcadia Biosciences FY2025 net loss attributable to common stockholders narrows 67% to $2.3 million; revenue drops 4% to $4.9 million

Reuters·03/26/2026 20:09:24

Please log in to view news